Histopathologic differentiation between localized and systemic scleroderma.
about
Histometric data obtained by in vivo confocal laser scanning microscopy in patients with systemic sclerosisHigh IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohortFibrillin assemblies: extracellular determinants of tissue formation and fibrosisHistopathological cutaneous alterations in systemic sclerosis: a clinicopathological studyPediatric scleroderma: systemic or localized formsPeripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study.Cytokine profiles in localized scleroderma and relationship to clinical features.The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measuresEvidence of an antifibrotic effect of immunosuppressive drugs: applications in the treatment of systemic sclerosis.Morphea and Eosinophilic Fasciitis: An Update.Clinicopathological study of 81 cases of localized and systemic scleroderma.Clinical utility of hypo- and hyperpigmentation of skin in diffuse cutaneous systemic sclerosis.Multiplex assessment of serum cytokine and chemokine levels in idiopathic morphea and vitamin K1-induced morphea.Histopathological changes in morphea and their clinical correlates: Results from the Morphea in Adults and Children Cohort V.
P2860
Q24799741-B12C9D21-2D77-40AC-AF26-990337555E2EQ34066564-5D6E8C4B-E9CB-4586-96DA-0765CEB40D17Q34415750-59B3B11C-4471-45D7-8669-0FC4AF882468Q34447925-F65AA776-9B37-425A-AC5E-17CD26542810Q35620376-AEC65ED7-6E4A-46A6-B0B1-18E09E8DD008Q36282971-CCCCDCBA-C9A5-4FBB-8B06-71684D5A6F17Q36307704-F9681629-0AA6-4E5E-BD50-3394F1B8C7AEQ36401559-1B344384-9AFE-43A3-BD29-FBBBD3380186Q36784652-EEBF2D85-2A92-4728-B102-049353C1AB25Q36949289-C05D78FD-4C2B-4565-BBD5-3BEC5F4FEFCDQ37754503-55E1AB43-E77F-40D5-BF08-57053A3D12C9Q38902145-23B750FA-CA05-4EAE-99F6-47A0EAA9A24DQ45375296-BC045F53-5856-454E-8D4D-6070D3511333Q47839424-8210F6C9-CC49-4887-90DB-75F2A3F04A10Q52903928-4F847A71-B2DD-4272-A14A-EF5814F8FDAFQ54912167-9F329436-7C93-4B4B-82F9-DFF8603E8781
P2860
Histopathologic differentiation between localized and systemic scleroderma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Histopathologic differentiation between localized and systemic scleroderma.
@en
Histopathologic differentiation between localized and systemic scleroderma.
@nl
type
label
Histopathologic differentiation between localized and systemic scleroderma.
@en
Histopathologic differentiation between localized and systemic scleroderma.
@nl
prefLabel
Histopathologic differentiation between localized and systemic scleroderma.
@en
Histopathologic differentiation between localized and systemic scleroderma.
@nl
P1476
Histopathologic differentiation between localized and systemic scleroderma.
@en
P2093
P304
P356
10.1097/00000372-199806000-00003
P577
1998-06-01T00:00:00Z